117 related articles for article (PubMed ID: 35112889)
1. Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death.
Brady PF; Chua W; Nehaj F; Connolly DL; Khashaba A; Purmah YJV; Ul-Qamar MJ; Thomas MR; Varma C; Schnabel RB; Zeller T; Fabritz L; Kirchhof PF
J Am Heart Assoc; 2022 Feb; 11(4):e022833. PubMed ID: 35112889
[TBL] [Abstract][Full Text] [Related]
2. Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study.
Chua W; Law JP; Cardoso VR; Purmah Y; Neculau G; Jawad-Ul-Qamar M; Russell K; Turner A; Tull SP; Nehaj F; Brady P; Kastner P; Ziegler A; Gkoutos GV; Pavlovic D; Ferro CJ; Kirchhof P; Fabritz L
PLoS Med; 2021 Feb; 18(2):e1003405. PubMed ID: 33534825
[TBL] [Abstract][Full Text] [Related]
3. N-Terminal Pro-Brain Type Natriuretic Peptide Predicts Cardiovascular Events Independently of Arterial Stiffness, Assessed By Carotid-to-Femoral Pulse Wave Velocity, in Apparently Healthy Subjects.
Frary CE; Blicher MK; Olesen TB; Pareek M; Vishram-Nielsen JKK; Rasmussen S; Olsen MH
Heart Lung Circ; 2024 Mar; 33(3):392-400. PubMed ID: 38290952
[TBL] [Abstract][Full Text] [Related]
4. Early changes in N-terminal pro-brain natriuretic peptide levels predict new-onset heart failure in patients with STEMI.
Del Buono MG; Trankle CR; Buckley L; Kadariya D; Canada JM; Carbone S; Turlington J; Markley R; Bressi E; VAN Tassell BW; Abbate A
Minerva Cardiol Angiol; 2022 Feb; 70(1):25-31. PubMed ID: 32657561
[TBL] [Abstract][Full Text] [Related]
5. Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.
Greene SJ; Fonarow GC; Solomon SD; Subacius HP; Ambrosy AP; Vaduganathan M; Maggioni AP; Böhm M; Lewis EF; Zannad F; Butler J; Gheorghiade M;
Eur J Heart Fail; 2017 Apr; 19(4):552-562. PubMed ID: 27748006
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE project.
Rehm M; Rothenbacher D; Iacoviello L; Costanzo S; Tunstall-Pedoe H; Fitton CA; Söderberg S; Hultdin J; Salomaa V; Jousilahti P; Palosaari T; Kuulasmaa K; Waldeyer C; Schnabel RB; Zeller T; Blankenberg S; Koenig W;
ESC Heart Fail; 2022 Feb; 9(1):57-65. PubMed ID: 34825788
[TBL] [Abstract][Full Text] [Related]
7. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study.
Jia X; Buckley L; Sun C; Al Rifai M; Yu B; Nambi V; Virani SS; Selvin E; Matsushita K; Hoogeveen RC; Coresh J; Shah AM; Ballantyne CM
Eur J Prev Cardiol; 2023 Nov; 30(16):1731-1740. PubMed ID: 37306504
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of serum NT-proBNP (fragments 1-76aa and 13-71aa) and galectin-3 in predicting death and re-hospitalisation due to cardiovascular events in patients with heart failure.
Zhang X; Wan Y; Karunathilaka N; Chan W; Kostner K; Hartel G; Coats AJS; Atherton JJ; Punyadeera C
Heart Vessels; 2024 Jan; 39(1):86-94. PubMed ID: 37537380
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic peptide testing strategies in heart failure: A 2023 update.
Chaikijurajai T; Rincon-Choles H; Tang WHW
Adv Clin Chem; 2024; 118():155-203. PubMed ID: 38280805
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D.
Baumhove L; Bomer N; Tromp J; van Essen BJ; Dickstein K; Cleland JG; Lang CC; Ng LL; Samani NJ; Anker SD; Metra M; van Veldhuisen DJ; van der Meer P; Voors AA
Int J Cardiol; 2024 Feb; 396():131384. PubMed ID: 37739044
[TBL] [Abstract][Full Text] [Related]
11. Multi-Ethnic Study of Atherosclerosis Early Heart Failure Study: Rationale, Design, and Baseline Characteristics.
Beussink-Nelson L; Freed BH; Chirinos JA; Brubaker PH; Kitzman DW; Yeboah J; Rosas SE; Hu M; Lima JAC; Pandit J; Bertoni AG; Shah SJ
Circ Heart Fail; 2024 Mar; 17(3):e010289. PubMed ID: 38456289
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of all-cause mortality in patients presenting to specialist heart failure clinic with raised NT-proBNP and no heart failure.
Garg P; Wood S; Swift AJ; Fent G; Lewis N; Rogers D; Rothman A; Charalampopoulos A; Al-Mohammad A
ESC Heart Fail; 2020 Aug; 7(4):1791-1800. PubMed ID: 32496010
[TBL] [Abstract][Full Text] [Related]
13. A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study).
Jonmundsson T; Steindorsdottir AE; Austin TR; Frick EA; Axelsson GT; Launer L; Psaty BM; Loureiro J; Orth AP; Aspelund T; Emilsson V; Floyd JS; Jennings L; Gudnason V; Gudmundsdottir V
Europace; 2023 Nov; 25(11):. PubMed ID: 37967346
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events.
Khan MS; Januzzi JL; Liu Y; Xu J; Shaw W; Sattar N; Mahaffey KW; Neal B; Hansen MK; Butler J
J Card Fail; 2024 Apr; ():. PubMed ID: 38614444
[TBL] [Abstract][Full Text] [Related]
15. NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure.
Schmitt W; Diedrich C; Hamza TH; Meyer M; Eissing T; Breitenstein S; Rossano JW; Lipshultz SE
Pediatr Cardiol; 2024 May; ():. PubMed ID: 38722325
[TBL] [Abstract][Full Text] [Related]
16. Reference intervals for N-terminal pro-B-type natriuretic peptide in amniotic fluid between 10 and 34 weeks of gestation.
Merz WM; Leufgen C; Fimmers R; Stoffel-Wagner B; Gembruch U
PLoS One; 2014; 9(12):e114416. PubMed ID: 25490554
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort.
Asselbergs FW; van den Berg MP; Bakker SJ; Signorovitch JE; Hillege HL; van Gilst WH; van Veldhuisen DJ
Neth Heart J; 2008; 16(3):73-8. PubMed ID: 18345329
[TBL] [Abstract][Full Text] [Related]
18. Frailty and Metabolic Vulnerability in Heart Failure: A Community Cohort Study.
Kumar S; Conners KM; Shearer JJ; Joo J; Turecamo S; Sampson M; Wolska A; Remaley AT; Connelly MA; Otvos JD; Larson NB; Bielinski SJ; Roger VL
J Am Heart Assoc; 2024 Apr; 13(8):e031616. PubMed ID: 38533960
[TBL] [Abstract][Full Text] [Related]
19. Natriuretic Peptide Normative Levels and Deficiency: The National Health and Nutrition Examination Survey.
Shetty NS; Patel N; Gaonkar M; Li P; Arora G; Arora P
JACC Heart Fail; 2024 Jan; 12(1):50-63. PubMed ID: 37768244
[TBL] [Abstract][Full Text] [Related]
20. Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study.
Chua W; Khashaba A; Canagarajah H; Nielsen JC; di Biase L; Haeusler KG; Hindricks G; Mont L; Piccini J; Schnabel RB; Schotten U; Wienhues-Thelen UH; Zeller T; Fabritz L; Kirchhof P
Europace; 2024 Feb; 26(2):. PubMed ID: 38266130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
